# Rapport Therapeutics, Inc.: Form 8-K, filed Jan 7, 2026

- Company: [Rapport Therapeutics, Inc.](/companies/rapp.md) (CIK 2012593)
- Form: 8-K
- Filed: 2026-01-07
- Accepted by EDGAR: Jan 7, 2026, 07:30 ET
- Period: 2026-01-07
- Accession: 0001193125-26-005446
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2012593/000119312526005446/rapp-20260107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2012593/000119312526005446/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2012593/000119312526005446/rapp-20260107.htm

Filed Jan 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-005446. Last ingested by Listed: Nov 4, 2026, 07:39 ET. No prices; not investment advice.